- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03185455
Remote Surveillance of Postpartum Hypertension (TextBP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypertension is a leading cause of maternal morbidity, mortality and obstetrical readmissions. Peak blood pressure usually occurs 3-6 days postpartum, and is typically unaccompanied by warning symptoms. Although there is a clear need for effective and reliable blood pressure surveillance after delivery, there are significant obstacles to in-person visits in the immediate postpartum period, including sleep deprivation, newborn care, and transportation needs. These barriers have proven real as we observed only 30-50% attendance to office blood pressure visits following delivery. This proposal will investigate whether text-based communication between patients and providers is an effective alternative method for monitoring postpartum hypertension in at risk women.
Women with hypertensive disorders of pregnancy with access to a cell phone with unlimited text message capabilities will be randomized to either office visit blood pressure checks after discharge or receive a blood pressure cuff and text in blood pressures for two weeks postpartum using a standardized, HIPAA compliant, physician derived automated platform.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women with chronic hypertension, gestational hypertension, or preeclampsia who deliver at the Hospital of the University of Pennsylvania will be eligible to participate. All patients must be > 18 years old, able to speak and read English, have a hypertension diagnosis, and have access to a cell phone with unlimited text message capabilities.
Exclusion Criteria:
- Women without access to a cell phone with unlimited text message capabilities will be excluded from the study in order to eliminate barriers to participate in remote surveillance. However, we will track the number of women not eligible for this reason in order to understand generalizability in an urban population.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of Care
Those randomized to the standard protocol for blood pressure monitoring will be scheduled for an office based nursing blood pressure visits 4-6 days postpartum.
Care at this visit is based on a physician derived algorithm.
|
|
|
Experimental: Remote (text based) surveillance
Those randomized to remote surveillance will be provided with electronic blood pressure monitors prior to discharge and instructed on their use.
Every day, for two weeks post-discharge, patients will receive a standard text message in the morning from a HIPAA compliant automated monitoring system reminding them to text their blood pressure.
They will be asked to send in one blood pressure a day at minimum.
They may be asked to send in more depending on the blood pressure result and clinical algorithm.
This system will provide timely responses to patient texts and create a physician derived response to elevated blood pressures based on a programmed algorithm.
Additionally, for blood pressures that reach a dangerous threshold, a clinical provider will be alerted per the algorithm and contact the patient for further evaluation.
|
Women with hypertensive disorders of pregnancy with access to a cell phone with unlimited text message capabilities will be randomized to either office visit blood pressure checks after discharge or receive a blood pressure cuff and text in blood pressures for two weeks postpartum using a standardized, HIPAA compliant, physician derived automated platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Whose Blood Pressure Was Assessed in the First Ten Days Following Discharge
Time Frame: 10 days postdischarge
|
the percentage of patients in which a single blood pressure is obtained in the first 10 days following discharge.
Within the texting group, the percentage of patients in whom blood pressures values are obtained at 72 hours and 7-10 days postpartum, in accordance with American College of Obstetricians and Gynecologists recommendations, will be assessed as well.
|
10 days postdischarge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Required Antihypertensive Medication Initiation or Dose Adjustment Within 2 Weeks Postpartum
Time Frame: 2 weeks postpartum
|
Number of participants who required antihypertensive medication initiation or dose adjustment within 2 weeks postpartum
|
2 weeks postpartum
|
|
Number of Participants Who Required Additional ER or Office Visits for Hypertension (Not Resulting in Readmission) Within 2 Weeks Postpartum
Time Frame: 2 weeks postpartum
|
Number of participants who required additional ER or office visits for hypertension (not resulting in readmission) within 2 weeks postpartum
|
2 weeks postpartum
|
|
Number of Participants With Hypertension Related Readmission Within 2 Weeks Postpartum
Time Frame: 2 weeks postpartum
|
Number of participants with hypertension related readmission within 2 weeks postpartum
|
2 weeks postpartum
|
|
Patient Satisfaction
Time Frame: 2 weeks postpartum
|
Patient who would recommend the program to a family or friend as per the Patient Satisfaction Survey completed at 2 weeks postpartum.
|
2 weeks postpartum
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 825390
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension in Pregnancy
-
University of Texas Southwestern Medical CenterNational Center for Advancing Translational Sciences (NCATS)CompletedChronic Hypertension in PregnancyUnited States
-
Icahn School of Medicine at Mount SinaiTerminatedHypertension in Pregnancy | Hypertension in PostpartumUnited States
-
Ain Shams Maternity HospitalUnknownUric Acid and Hypertension in PregnancyEgypt
-
Rutgers, The State University of New JerseyNational Center for Advancing Translational Sciences (NCATS)Not yet recruitingChronic Hypertension in PregnancyUnited States
-
Dr Cipto Mangunkusumo General HospitalActive, not recruiting
-
Wake Forest University Health SciencesRecruiting
-
University of MessinaCompletedHypertension in Pregnancy | Diabetes Mellitus in PregnancyItaly
-
St George's, University of LondonNational Institute for Health Research, United KingdomRecruiting
-
University College CorkScience Foundation IrelandUnknown
-
University of Mississippi Medical CenterUniversity of ChicagoCompleted
Clinical Trials on Remote (text based) surveillance
-
Women and Infants Hospital of Rhode IslandCompletedPreeclampsia | Gestational Hypertension | Chronic Hypertension Complicating PregnancyUnited States
-
Columbia UniversityCenters for Disease Control and PreventionCompleted
-
Columbia UniversityCenters for Disease Control and PreventionCompleted
-
Columbia UniversityCenters for Disease Control and PreventionCompleted
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Federico II UniversityRecruitingHeart Failure | Sudden Cardiac Death | Cardiac ArrhythmiasItaly
-
University of PittsburghUniversity of Michigan; Allegheny Singer Research Institute (also known as...Completed
-
Universidade Cidade de Sao PauloCompletedRunning-related InjuriesBrazil
-
Ontario Medical AssociationThe Behavioural Insights TeamCompletedAnxiety | Mental Health Wellness 1 | HappinessCanada
-
Thomas Jefferson UniversityCompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States